1. Home
  2. STAA vs ANIP Comparison

STAA vs ANIP Comparison

Compare STAA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$22.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$69.68

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAA
ANIP
Founded
1982
2001
Country
United States
United States
Employees
957
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.9B
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
STAA
ANIP
Price
$22.65
$69.68
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$22.81
$110.00
AVG Volume (30 Days)
874.6K
315.7K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
0.26
2.32
Revenue
$239,442,000.00
$206,547,000.00
Revenue This Year
$30.82
$21.01
Revenue Next Year
$8.41
$17.59
P/E Ratio
$90.85
$30.47
Revenue Growth
N/A
2.47
52 Week Low
$15.59
$69.96
52 Week High
$35.87
$99.39

Technical Indicators

Market Signals
Indicator
STAA
ANIP
Relative Strength Index (RSI) 47.81 35.89
Support Level $23.27 $70.15
Resistance Level $24.26 $83.20
Average True Range (ATR) 0.82 1.79
MACD 0.17 -0.21
Stochastic Oscillator 70.13 10.32

Price Performance

Historical Comparison
STAA
ANIP

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: